Virtual Screening

Closed Solicitation Posted

Solicitation number
75N92024Q1061
Agency
National Heart Lung and Blood Institute National Institutes of Health, Department of Health and Human Services
Responses due
Set-aside
Total Small Business

Opportunity facts

NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
Q301 Reference Laboratory Testing
Points of contact
More information

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute is seeking virtual screening for compounds that increase GALNT3 mutation stability through a small business set-aside contract. The contract will require research and development in biotechnology, as well as reference laboratory testing services. Key evaluation criteria include the offeror's ability to meet the technical requirements and timeline, with proposals due by August 27, 2024.

This is a total small business set-aside contract. No incumbent or current contractor information is provided. The anticipated award value and budget range are not specified. The place of performance is not stated, but the work is likely to be conducted at the offeror's facilities.

Notice text

Virtual Screening for compounds increasing GALNT3 mutation stability

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity